Our R&D park is capable to handle the full cycle of development of any medication from molecule design to commercial production. We primarily focus of rare diseases that lack due therapy.

We control the quality of the medications throughout the entire life cycle of preparation. Not only industrial production meets GMP requirements. Development, preclinical and scientific research are carried out in strict accordance with international quality standards GLP and GCP.

Scientific research is carried out together with biotechnological companies and scientific institutions from around the world

We develop medications for the treatment of severe hereditary and life-threatening diseases.